The move was driven in large part by a sharp rally in bonds and a declining dollar. Weak economic data helped to cool off some of the concerns about inflation. After the close, earnings from Alphabet and Microsoft disappointed the market, and the Nasdaq 100 is giving back the majority of Tuesday's gains. Read More...
Motley Fool
Why Medpace Stock Soared Today
Shares of Medpace Holdings (NASDAQ: MEDP) surged 37.7% on Tuesday after the clinical contract research organization (CRO) delivered strong third-quarter results and issued an optimistic financial forecast for the year ahead. Medpace’s revenue jumped 30% year over year to $383.7 million, easily outpacing Wall Street’s estimates of roughly $357 million. The healthcare company, which helps pharmaceutical, biotechnology, and medical device companies conduct clinical trials, also saw its backlog grow by 21% to $2.2 billion as of the end of September.
Add Comment